Diagnosis and management of early asthma in preschool-aged children.
暂无分享,去创建一个
[1] W. Busse,et al. Middleton's Allergy: Principles and Practice , 2013 .
[2] T. van der Molen,et al. Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial. , 2008, Pulmonary pharmacology & therapeutics.
[3] B. Nickerson,et al. Lung function measurement in the assessment of childhood asthma: recent important developments , 2010, Current opinion in allergy and clinical immunology.
[4] G. Shapiro,et al. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. , 1998, The Journal of allergy and clinical immunology.
[5] M. Welch,et al. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. , 1999, Pediatrics.
[6] J. Castro‐Rodriguez,et al. The Asthma Predictive Index: a very useful tool for predicting asthma in young children. , 2010, The Journal of allergy and clinical immunology.
[7] J. Warner. Asthma in Infancy and Childhood , 2009 .
[8] C. Sorkness,et al. Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. , 2011, The Journal of allergy and clinical immunology.
[9] B. Chipps. Intermittent Inhaled Corticosteroids in Infants With Episodic Wheezing , 2007, Pediatrics.
[10] H. Derkx,et al. Gastroesophageal reflux in infants with wheezing. , 2000, Pediatric pulmonology.
[11] S. Sekhsaria,et al. Efficacy and Safety of Inhaled Corticosteroids in Combination with a Long‐Acting Beta2‐Agonist in Asthmatic Children Under Age 5 , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.
[12] D. Allen. Inhaled steroids for children: effects on growth, bone, and adrenal function. , 2005, Endocrinology and metabolism clinics of North America.
[13] M. Sears,et al. Attenuation of the September Epidemic of Asthma Exacerbations in Children: A Randomized, Controlled Trial of Montelukast Added to Usual Therapy , 2007, Pediatrics.
[14] Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009. , 2011, MMWR. Morbidity and mortality weekly report.
[15] H. Bisgaard,et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach , 2008, European Respiratory Journal.
[16] H. Bisgaard,et al. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. , 1999, American journal of respiratory and critical care medicine.
[17] J. Castro‐Rodriguez,et al. Efficacy of Inhaled Corticosteroids in Infants and Preschoolers with Recurrent Wheezing and Asthma: A Systematic Review with Meta-Analysis. , 2009, ATS 2009.
[18] J. Warner. Wheezing Disorders in the Preschool Child: Pathogenesis and Management , 2004 .
[19] Z. Zonis,et al. Diagnostic evaluation of foreign body aspiration in children: a prospective study. , 2005, Journal of pediatric surgery.
[20] N. Santanello,et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. , 2001, Pediatrics.
[21] T. Green,et al. Montelukast Reduces Asthma Exacerbations in 2- to 5-Year-Old Children With Intermittent Asthma , 2006, Pediatrics.
[22] Ayne,et al. ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFE , 1995 .
[23] D. Postma,et al. Comparison of childhood wheezing phenotypes in 2 birth cohorts: ALSPAC and PIAMA. , 2011, The Journal of allergy and clinical immunology.
[24] M. Malice,et al. Analysis of behavior-related adverse experiences in clinical trials of montelukast. , 2009, The Journal of allergy and clinical immunology.
[25] R. Platt,et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. , 2009, The New England journal of medicine.
[26] R. Castile. Novel Techniques for Assessing Infant and Pediatric Lung Function and Structure , 2004, The Pediatric infectious disease journal.
[27] K. Carlsen,et al. Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age , 2007, Thorax.
[28] L. Bacharier,et al. Phenotypic Expressions of Childhood Wheezing and Asthma: Implications for Therapy , 2011, The Journal of Pediatrics.
[29] Stefano Guerra,et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. , 2005, American journal of respiratory and critical care medicine.
[30] Peter D Sly,et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger , 2011, Pediatric pulmonology.
[31] C. Sorkness,et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. , 2004, The Journal of allergy and clinical immunology.
[32] W. Freeman,et al. Can we predict which wheezy infants will continue to wheeze? , 1999, American journal of respiratory and critical care medicine.
[33] M. Newhouse,et al. Factors that affect the efficacy of inhaled corticosteroids for infants and young children. , 2010, The Journal of allergy and clinical immunology.
[34] E. Valovirta,et al. Intermittent or daily montelukast versus placebo for episodic asthma in children. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[35] D. Sherrill,et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years , 1999, The Lancet.
[36] A. Boner,et al. Regular vs prn nebulized treatment in wheeze preschool children , 2009, Allergy.
[37] S. Holgate,et al. Characterization of wheezing phenotypes in the first 10 years of life , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[38] S. Szefler,et al. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma. , 2002, The Journal of allergy and clinical immunology.
[39] J. Kemp,et al. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[40] S. Szefler,et al. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. , 2007, The Journal of allergy and clinical immunology.
[41] N. Santanello,et al. Response to montelukast among subgroups of children aged 2 to 14 years with asthma. , 2003, The Journal of allergy and clinical immunology.
[42] L. Bacharier. Evaluation of the child with recurrent wheezing. , 2011, The Journal of allergy and clinical immunology.
[43] J. Castro‐Rodriguez. The Asthma Predictive Index: early diagnosis of asthma , 2011, Current opinion in allergy and clinical immunology.
[44] L. Bacharier,et al. Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. , 2009, The Journal of allergy and clinical immunology.
[45] H. Bisgaard,et al. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. , 2004, Pediatrics.
[46] A. Kaditis,et al. Anti‐inflammatory pharmacotherapy for wheezing in preschool children , 2007, Pediatric pulmonology.
[47] Amanda J Lee,et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. , 2007, American journal of respiratory and critical care medicine.
[48] T. Guilbert. Identifying and managing the infant and toddler at risk for asthma. , 2010, The Journal of allergy and clinical immunology.
[49] D. Vilozni,et al. The effect of montelukast on bronchial hyperreactivity in preschool children. , 2007, Chest.
[50] E. Baraldi,et al. Bronchopulmonary dysplasia: definitions and long-term respiratory outcome. , 2009, Early human development.
[51] M. Schatz,et al. Daily or intermittent budesonide in preschool children with recurrent wheezing. , 2011, The New England journal of medicine.
[52] W. Morgan,et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.
[53] C. Sorkness,et al. Classifying asthma severity in children: Is measuring lung function helpful? , 2002 .
[54] A. Biggeri,et al. Risk Factors for Early, Persistent, and Late-onset Wheezing in Young Children , 1999 .
[55] H. Bisgaard,et al. Response of preschool children with asthma symptoms to fluticasone propionate. , 2001, The Journal of allergy and clinical immunology.
[56] S. Szefler,et al. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. , 2000, The Journal of allergy and clinical immunology.
[57] D. Strachan,et al. Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood , 2008, Thorax.
[58] A. Goldsobel. Lansoprazole for Children With Poorly Controlled Asthma: A Randomized Controlled Trial , 2012, Pediatrics.
[59] P. Sly,et al. The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze , 2009, Acta paediatrica.
[60] H. Bisgaard,et al. Safety and tolerability of montelukast in placebo‐controlled pediatric studies and their open‐label extensions , 2009, Pediatric pulmonology.
[61] C. Sorkness,et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. , 2008, The Journal of allergy and clinical immunology.
[62] B. Chipps. Long-term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma , 2007, Pediatrics.
[63] Bert Brunekreef,et al. Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. , 2009, The Journal of allergy and clinical immunology.
[64] J. Castro‐Rodriguez,et al. Efficacy of Inhaled Corticosteroids in Infants and Preschoolers With Recurrent Wheezing and Asthma: A Systematic Review With Meta-analysis , 2009, Pediatrics.
[65] A. Biggeri,et al. Risk factors for early, persistent, and late-onset wheezing in young children. SIDRIA Collaborative Group. , 1999, American journal of respiratory and critical care medicine.
[66] P. Brand,et al. Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. , 2011, Respiratory medicine.
[67] Varinder Singh,et al. Diagnostic modalities for gastro-esophageal reflux in infantile wheezers. , 2011, Journal of tropical pediatrics.
[68] J. Castro‐Rodriguez,et al. A clinical index to define risk of asthma in young children with recurrent wheezing. , 2000, American journal of respiratory and critical care medicine.
[69] Alfred O. Berg,et al. Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .
[70] L. Bacharier,et al. Severe intermittent wheezing in preschool children: a distinct phenotype. , 2007, The Journal of allergy and clinical immunology.
[71] Wei Wu,et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[72] S. Harding. Gastroesophageal reflux and asthma: insight into the association. , 1999, The Journal of allergy and clinical immunology.
[73] A. Moeller,et al. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children , 2008, Pediatric pulmonology.
[74] Even Lea,et al. Diagnostic evaluation of foreign body aspiration in children: a prospective study , 2005 .
[75] A. Woodcock,et al. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study , 2006, The Lancet.
[76] C. Crim,et al. Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study. , 2006, The Journal of pediatrics.
[77] J. de Blic,et al. The use of imaging techniques for assessing severe childhood asthma. , 2007, The Journal of allergy and clinical immunology.
[78] Urs Frey,et al. Validation of the Asthma Predictive Index and comparison with simpler clinical prediction rules. , 2011, The Journal of allergy and clinical immunology.